Eugene, Oregon
United States
11
2018-07-26
10
2020-01-28
These are the the leading inventors for applications assigned to Marker Gene Technologies, Inc.:
Marker Gene Technologies, Inc. based in Eugene, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Targeted peptide conjugates
#2 | 2018-05-03 ✅ Patent 10,401,361 granted on 2019-09-03Intracellular organelle peptide targeted enzyme substrates
#3 | 2017-08-03 ✅ Patent 9,925,271 granted on 2018-03-27Targeted pharmacological chaperones
#4 | 2016-08-11 ✅ Patent 9,610,358 granted on 2017-04-04Targeted pharmacological chaperones
#5 | 2015-08-06 ✅ Patent 9,841,426 granted on 2017-12-12Intracellular organelle peptide targeted enzyme substrates
#6 | 2014-03-27Synthetic luciferase gene and protein
#7 | 2013-09-26 ✅ Patent 9,677,115 granted on 2017-06-13Enzyme substrates for visualizing acidic organelles
#8 | 2012-02-09 ✅ Patent 8,206,961 granted on 2012-06-26Modified luciferase protein
#9 | 2012-02-02 ✅ Patent 8,450,054 granted on 2013-05-28Modified luciferase gene and protein
#10 | 2010-04-15 ✅ Patent 7,723,502 granted on 2010-05-25Modified luciferase gene and protein
#11 | 2006-05-18 ✅ Patent 8,716,558 granted on 2014-05-06Method of altering glycosylation of proteins in response to nojirimycin glucuronide in a plant cell expressing glucuronidase
Also check out Marker Gene Technologies, Inc.'s (Eugene, United States) applicant profile with 6 patent applications submitted.
40470 ⎘